Picture of Novartis AG logo

NOVN Novartis AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

RCS - Motorica - Motorica Raises €5M

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250624:nRSX2173Oa&default-theme=true

RNS Number : 2173O  Motorica  24 June 2025

Motorica Raises €5M to Lead the Generative AI Revolution in Character
Animation

Trusted by top-tier AAA studios and animators, Motorica delivers
production-ready motion synthesis at 200x speed, with no compromise on quality
or control

STOCKHOLM, SE / ACCESS Newswire / June 24, 2025 / Motorica
(https://pr.report/brsn) , the global pioneer in Generative AI for character
animation and motion synthesis, today announced the close of a €5 million
seed funding round, led by Angular Ventures, with participation from Luminar
Ventures. The funding will support Motorica's rapid expansion, scaling of its
proprietary AI platform and continued investment in R&D to shape the
future of instant character animation.

Motorica's technology is already being used in live production environments by
world-leading AAA studios to deliver production-ready animation at
unprecedented speed and scale. In early deployments, studios have reported up
to a 99% reduction in animation time, achieving animation workflows that are
200x faster than the traditional motion capture to gameplay animation workflow
- without sacrificing creative control, quality, or pipeline compatibility.

"Motorica is a breakthrough in game development and animation technology that
will help to bring forth the next era of gaming, enabling digital Living
Worlds that are populated by dynamic, lifelike characters that will make
gameplay a truly immersive and interactive experience," said Willem Demmers,
CEO of Motorica. "But unlike other AI developments, we're not here to upend
the animation workflow. We're here to liberate it. Traditionally, animators
spend 70% of their time on technical grunt work and only 30% on actual
creative performance. Motorica flips that. By automating the grind - things
like tedious keyframing for basic locomotion - we let creators focus on what
matters: storytelling, emotion, and innovation. That shift helps studios move
faster, push quality higher, and ship with less friction."

Maxi Keller, animator for titles including "The Last of Us: Part II" and "Call
of Duty: WWll," shared, "Motorica is the best tool out there for locomotion
animation and Motion Matching. It delivers better, more consistent results
than mocap as they give you exact control on acceleration and target speed,
and more."

Solving the Hardest Problem in Game and Virtual Production Pipelines

Character animation, especially for interactive media like games and virtual
production, has traditionally required a significant amount of manual work,
from in-studio MoCap shoots and reshoots to manual keyframing and repetitive
cycles. Studios face a fundamental trade-off between speed and cost versus
realism and scale. Motorica removes that trade-off.

Motorica's platform is built to generate realistic, responsive, diverse
animation at scale. The system integrates industry-standard tools and
workflows, offering full compatibility with DCC software and game engines,
including Unreal Engine, Maxon Cinema 4D, Maya, Unity and Blender. Advanced
capabilities include support for motion matching, enabling lifelike animation
for large numbers of characters in complex gameplay scenarios.

Motorica Highlights:

·      Massive acceleration in animation production. One studio
estimated three years of animation can be completed in just four days.

·      More expressive and stylistically diverse characters, generated
using smaller datasets.

·      Substantial cost savings on accelerated mocap sessions and
post-processing.

Built on Breakthrough Research and Proprietary Datasets

Motorica's core IP is built on years of academic innovation, beginning with
the 2019 research breakthrough by top researchers Gustav Henter and Simon
Alexanderson, who developed the world's first deep generative model for motion
synthesis - effectively pioneering generative AI for character animation.
Founded in 2020 to prototype this research, Motorica officially broke stealth
in 2023, when Gustav and Simon teamed up with serial founder Willem Demmers to
bring the company to market - turning their pioneering prototype into a
commercially viable product.

Motorica owns and operates a state-of-the-art motion capture studio in
Stockholm and has built one of the largest and most refined proprietary motion
datasets in the world, captured with professional actors to ensure
biomechanical realism and cinematic performance. With this foundation,
Motorica stands alone as the only generative AI provider currently delivering
AAA-quality animation at scale and as the category leader in the emerging
space of motion synthesis.

"We invested in Motorica because they're not just reimagining animation -
they're building foundational technology that will power the next wave of
digital experiences," said David Peterson, Partner at Angular Ventures. "This
platform has the potential to influence everything from how characters move in
games and virtual worlds to how machines understand and replicate human motion
in robotics, XR, and beyond. Their deep research roots, execution strength,
and early adoption from industry leaders make Motorica a category-defining
company."

With seed funding secured, Motorica plans to accelerate its product roadmap
and scale customer adoption across key verticals. Near-term initiatives
include:

·      Expanding integrations via SDKs and APIs to make Motorica even
more plug-and-play for game studios, cinematics and virtual production teams.

·      Growing the company's data infrastructure and motion library,
adding tools for controllable motion within fighting, sports, and stylized
movement.

·      Launching strategic partnerships with game engines, simulation
platforms, and large scale VFX studios.

·      Hiring across engineering, animation, data, and customer success.

Artist Commitment

Motorica's team is committed to augmenting creativity, not automating it away.
Rapidly emerging as the industry standard for high-quality motion synthesis,
the platform is designed in close collaboration with professional animators,
game developers, and technical directors to enhance artistic workflows and
eliminate bottlenecks. Rather than replacing human creativity, Motorica's
tools eliminate chores - such as character locomotion and filler cycles -
allowing creative teams to focus on performance, narrative, and style.

Download the Motorica media kit here (https://pr.report/brso) .

About Motorica

Motorica is a Stockholm-based AI company focused on generative animation for
3D character motion. Founded to address the growing demand for scalable,
high-quality animation, Motorica develops technology that combines machine
learning, motion capture, and compatible solutions for industry tools such as
motion matching.

Related Image
(https://app.accessnewswire.com/imagelibrary/906416f3-fb03-4b1f-8d63-828c80b02f34/1042323/9.png)

Press Contact

Megan Fasy

megan@grithaus.agency

+1 (617) 480-3674

###

SOURCE: Motorica

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFZGZVZDFGKZM

Recent news on Novartis AG

See all news